Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Debt (2020 - 2025)

Historic Total Debt for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $58.7 million.

  • NeuroPace's Total Debt fell 87.4% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year decrease of 87.4%. This contributed to the annual value of $59.5 million for FY2024, which is 451.42% up from last year.
  • As of Q3 2025, NeuroPace's Total Debt stood at $58.7 million, which was down 87.4% from $58.6 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Total Debt ranged from a high of $59.8 million in Q1 2025 and a low of $49.4 million during Q2 2021
  • Moreover, its 5-year median value for Total Debt was $54.9 million (2023), whereas its average is $54.9 million.
  • Its Total Debt has fluctuated over the past 5 years, first tumbled by 571.2% in 2022, then soared by 776.1% in 2024.
  • NeuroPace's Total Debt (Quarter) stood at $49.8 million in 2021, then grew by 6.15% to $52.9 million in 2022, then rose by 7.64% to $57.0 million in 2023, then grew by 4.51% to $59.5 million in 2024, then dropped by 1.31% to $58.7 million in 2025.
  • Its last three reported values are $58.7 million in Q3 2025, $58.6 million for Q2 2025, and $59.8 million during Q1 2025.